Monday, August 10, 2026

Light/Dark

Breaking News

Oxford Risk: Placing the Human at the Center of Wealth and Asset Management Transformation CLS Appoints Six New Board Directors Mobey Forum Calls for a Collaborative Approach to Fraud Prevention in Rethinking Fraud in a Connected World SumUp Launches in Canada European Fintech Association Elects New Board of Directors G+D: Navigating the Future of Fintech Agility and Innovation Connect IFA Strengthens Leadership Team to Drive Growth and Enhance Adviser Support FreeAgent Launches New AI Tool for Landlords to Capture Rental Statements EXCLUSIVE: “Keeping The Rubber on Track” – Nick Kerigan, Swift in ‘The Fintech Magazine’ Megadeals Are Back. Here’s Why J-P Conte Thinks Patient Capital Still Wins. A New Way to Get Paid: Modulr Adds cVRP to Its Collections Hub DIFC Future of Finance Report: Digital Native, AI Driven Challenger Banks Redefining Banking Models, Signalling Industry’s Biggest Shift Since 2008 UK Financial Institutions Look to Decade of AI-Driven Growth as Confidence Strengthens LUMIQ Raises Strategic Funding to Become the AI Decision Layer for Financial Services easypaisa and Binance Sign MoU to Explore Emerging Financial Technology Growth in Pakistan

Home » Companies » Valo Therapeutics Ltd

Connect

About Valo Therapeutics Ltd

About Valo Therapeutics Ltd

News

News

Peptichip Cancer

ValoTX Secures €2.23M for Microchip Based Peptichip Cancer Technology

February 13 2023

Valo Therapeutics, the developer of novel, adaptable immunotherapies for cancer and infectious diseases, announces that it […]

Dr Otto Kari

Dr Otto Kari

Paul Higham

Paul Higham